Marathon Oil and 3 Stocks with New Analyst Ratings and Price Targets

Marathon Oil Corporation (NYSE:MRO): Current price $34.63

Oppenheimer increased their price target on Marathon Oil Corporation as the firm believes that refiners are benefiting from several catalysts including low natural gas prices and growing exports. The firm also expects Marathon to benefit from the completion of the Detroit refinery upgrade and the acquisition of BP’s (NYSE:BP) Texas City refinery, they maintain an Outperform rating on the stock.

Your 1 Feature Stock Pick for February is hot off the press. Click here to discover it now!


Life Technologies Corporation (NASDAQ:LIFE): Current price $64.45

Following better than expected fourth quarter results, Baird raised their price target on Life Technologies Corporation. The firm cited improving fundamentals, solid momentum, and above Street guidance. Baird noted shares could be weak on disappointment due to no formal announcement regarding the company’s strategic review. Shares are Outperform rated.


ADTRAN Inc. (NASDAQ:ADTN): Current price $20.46

Stephens believes that Adtran Inc.’s stock sold off, yesterday, partly because investors thought that they are a major competitor of Acme Packet (NASDAQ:APKT), which was acquired by Oracle (NASDAQ:ORCL). However, Stephens reported that there is no major overlap between the companies, and they think that Adtran’s shares can jump about 30% in 2013.


Gilead Sciences Inc. (NASDAQ:GILD): Current price $40.64

Needham raised their price target for Gilead Sciences Inc., following the company’s fourth quarter results and reiterates a Buy rating on the stock.